Cancer chemoprevention with the adrenocortical steroid dehydroepiandrosterone and structural analogs

This publication has 31 references indexed in Scilit:

• Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production
  Antimicrobial Agents and Chemotherapy, 1992
• Dehydroepiandrosterone and Structural Analogs: A New Class of Cancer Chemopreventive Agents
  Advances in Cancer Research, 1988
• Phenotypic modulation of hepatocarcinogenesis and reduction in N-nitrosomorpholine-induced hemangiosarcoma and adrenal lesion development in Sprague-Dawley rats by dehydroepiandrosterone
  Carcinogenesis: Integrative Cancer Research, 1988
• Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone
  Advances in Enzyme Regulation, 1987
• Inhibition of Proteinuria Development in Aging Sprague-Dawley Rats and C57BL/6 Mice by Long-Term Treatment with Dehydroepiandrosterone
  Journal of Gerontology, 1986
• Modifying influence of dehydroepiandrosterone on the development of dihydroxy-di-n-propylnitrosamine-initiated lesions in the thyroid, lung and liver of F344 rats
  Carcinogenesis: Integrative Cancer Research, 1985
• Dehydroepiandrosterone (DHEA) and 3β-methylandrost-5-en-17-one: inhibitors of 7,12-dimethylbenz[a]anthracene (DMBA)-initiated and 12-O-tetradecanoylphorbol-13-acetate (TPA)-promoted skin papilloma formation in mice
  Carcinogenesis: Integrative Cancer Research, 1984
• The enzymatic basis for production by human neutrophils
  Canadian Journal of Physiology and Pharmacology, 1982
• Therapeutic Effects of Dehydroepiandrosterone (DHEA) in Diabetic Mice
  Diabetes, 1982
• Prevention of obesity in A^vy/a mice by dehydroepiandrosterone
  Lipids, 1977